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Summary
Objective: Murine brachymorphism (bm) results from an autosomal recessive mutation of the Papss2 gene that encodes 3#-
phosphoadenosine 5#-phosphosulfate synthetase 2, one of the principal enzymes required for the sulfation of extracellular matrix molecules
in cartilage and other tissues. A spondyloepimetaphyseal dysplasia has been identiﬁed in Pakistani kindred having a mutation of PAPSS2. In
addition to skeletal malformations that include short stature evident at birth due to limb shortening, brachydactyly, and kyphoscoliosis [AhmadM,
Haque MF, Ahmad W, Abbas H, Haque S, Krakow D, et al. Distinct, autosomal recessive form of spondyloepimetaphyseal dysplasia
segregating in an inbred Pakistani kindred. Am J Med Genet 1998;78:468e73], affected individuals demonstrate premature onset
degenerative joint disease. We investigated whether loss of Papss2 activity would similarly lead to degenerative joint disease in mice.
Methods: Mice carrying the bm mutation on a C57BL/6 background were obtained from the Jackson Laboratory. Limbs were analyzed by
micro-computed tomography (mCT) and histology.
Results: At 12 months of age both male and female bm mice exhibited severe degenerative knee joint disease, with cartilage damage being
primarily evident in the patello-femoral and medial compartments. Control 12e14-month-old C57BL/6 mice, in contrast, only occasionally
demonstrated minimal cartilage damage. mCT imaging of bm limbs revealed shortened diaphyses associated with ﬂared metaphyses in the
proximal elements of both fore and hind limbs. Additionally, the bm hind limbs demonstrated extensive structural alterations, characterized by
distortion of the patello-femoral groove, and prominent bowing of both tibia and ﬁbula.
Conclusions: The bm mutant, which develops severe articular cartilage lesions of the knee joint by approximately 12 months of age,
represents a novel example of murine degenerative joint disease, possibly representing a model of human PAPSS2 deﬁciency-associated
arthrosis.
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Murine brachymorphism (bm) results from an autosomal
recessive mutation of one of the genes (Papss2) encoding
3#-phosphoadenosine 5#-phosphosulfate synthetase 21e5,
an enzyme required for sulfation reactions on a variety of
different substrates. Papss2 is a bi-functional enzyme,
having both adenosine triphosphate (ATP)-sulfurylase and
adenosine-5#-phosphosulfate (APS)-kinase activities. After
sulfate import into the cell, this molecule is converted (by
reaction with ATP) into the ‘high energy’ species, phosphoa-
denosine-phosphosulfate (PAPS). PAPS is subsequently
translocated into the Golgi where the sulfate groups are
transferred, by a sulfotransferase, onto a variety of different
recipient molecules. Sulfate group addition is important in
419Osteoarthritis and Cartilage Vol. 13, No. 5many contexts, including, the deactivation or activation of
xenobiotics, hormone (e.g., catecholamine) inactivation,
elimination of speciﬁc end-products of catabolism, and in
maintaining both the structure and function of extracellular
matrix (ECM) macromolecules6. With respect to the latter,
one of the key substrates of sulfation reactions are the
glycosaminoglycans (GAGs)1,7, disaccharide units that are
covalently linked to the core proteins of proteoglycans.
The Papss2 defect in brachymorphic mice results from
a point mutation causing a Gly to Arg substitution within
a highly-conserved region of the APS kinase domain that
greatly impairs enzymatic activity5. Although bm/bm carti-
lage contains normal levels of GAGs, these are hyposul-
fated1,2,7, and as a result, less negatively charged than the
GAGs of control cartilage2. Although bm/bm mouse
cartilage matrix contained normal collagen ﬁbrils, proteo-
glycans aggregate granules were smaller and reduced in
number as compared to control mice, particularly in the
columnar and hypertrophic zones of the growth plate7. It
has also been suggested that premature mineralization may
occur in the bm/bm mice given that hyposulfated proteo-
glycans are less effective at inhibiting hydroxyapatite
deposition8,9.The bm/bm mouse phenotype is characterized by
foreshortened limbs, a short stout tail, and a complex
craniofacial phenotype (responsible for the characteristic
dome-shaped cranium of these mutant mice) whose origin
remains to be fully elucidated. Despite these abnormalities,
bm/bm mice are fertile, and have normal life-spans10.
Consistent with the role of the Papss2 in sulfate donation,
bm/bm mice exhibit abnormal hepatic detoxiﬁcation of
speciﬁc chemicals, increased bleeding times (attributed to
platelet dysfunction), and diminished postnatal growth due
to epiphyseal growth plate disruption. The latter results in
bm/bm limbs being w50% shorter than control limbs by 4
weeks of age, and axial skeleton length being reduced by
w25%.
Recently, a novel form of spondyloepimetaphyseal
dysplasia (SEMD) was reported in a Pakistani kindred, that
was associated with a truncation mutation of the human
PAPSS2 gene11,12. Affected individuals exhibited various
skeletal malformations, including short stature (already
evident at birth), short bowed lower limbs (genu varum),
mild brachydactyly, and kyphoscoliosis11. They also ex-
hibited early onset of an osteoarthritis-like degenerative
disease in various joints, including knees, hands, and spine.Fig. 1. 3D reconstruction of left humeri and knees from representative 12-month-old normal (left) and bm/bm (right) mice. The image of the
humeri (A) illustrates the distinctive limb morphology of the bm/bm mutant. Also shown are posterior (B), anterior (C), and lateral (D) views of
the knees: bowing of the tibia is seen in the bm/bm mice (B, C) compared to controls; and the enlarged, anteriorly-displaced patellar groove
(with overlying patella), as well as the excessive growth of the tibial tuberosity resulting in a ﬁn-like structure in the bm/bm sample, are best
seen in panel D.
420 A. F. Ford-Hutchinson et al.: Joint disease in Papss2 deﬁcient miceAlthough degenerative joint disease had not been pre-
viously reported, we hypothesized that brachymorph mice
would also show cartilage pathology with age.
Materials and methods
ANIMALS
Mice homozygous for the Papss2 gene mutation,
bm/bm, on a C57BL/6 background were obtained from
Jackson Laboratories (Bar Harbor, ME, USA). Six
C57BL/6 control mice (three males and three females)
were examined at 12e14 months of age, and four (one
male and three females) at 6e9 months. Six bm/bm mice
(three males and three females) were examined at 12
months, and three at 6e7 months of age (two males and
one female). Mice were maintained in a barrier facility in
accord with University of Calgary Animal Care Committee
and Canadian Council on Animal Care guidelines, and
euthanized by CO2 inhalation. Limbs to be scanned were
removed at the level of the hip and shoulder. Following
dissection, limbs to be examined by histology were
immediately placed in 10% neutral buffered formalin for
ﬁxation and then processed for histological examination.
Skeletal samples to be examined by micro-computed
tomography (mCT) were stored at 20(C. We have
established that cryopreservation does not alter the
morphology of skeletal samples for mCT.mCT ANALYSIS
Intact limbs were scanned using a Skyscan 107
(Aartselaar, Belgium) as described in Ford-Hutchinson
et al.13. Two isotropic scan resolutions, 15, and 5 mm, were
used for the visualization of gross limb morphology, and
morphometric analysis of proximal tibial subchondral plates,
respectively. Three-dimensional (3D) volumetric renderings
were produced using Analyze 5.0 (AnalyzeDirect, Lenexa,
KS). Software provided with scanner was used to measure
the 3D thickness distributions of the tibial plateaus, using
a model-independent method14. The proximal articular
surfaces of the tibia were segmented manually prior to
morphometric analysis using the same software.
HISTOLOGY
Hind limbs were transected 1 cm above and below the
knee joint line, ﬁxed in 10% neutral buffered formalin (Fisher
Scientiﬁc) for 7 d and then decalciﬁed in either Cal Ex, or
Cal Ex II (Fisher Scientiﬁc), for 10e14 d at room temper-
ature, with daily changes of the solution. Following de-
calciﬁcation, joints were thoroughly rinsed with water,
dehydrated, cleared and then inﬁltrated using an automatic
processor (Autotechnicon Mono 2A). Parafﬁn wax-embed-
ded tissue blocks were cut (8 mm serial sagittal sections)
and mounted on glass slides, with every other slide being
sequentially stained with hematoxylin, fast green, and
safranin-O (VWR), and mounted with Permount (Fisher).Fig. 2. Matched pairs of sagittal sections taken through the femoral condyles of representative 12-month-old control (A, C) and bm/bm (B, D)
mice. A and B illustrate the medial compartments, C and D the patello-femoral compartments of the knees. Note the altered, hammer head-like
(inverted in this image) shape of the distal femur in the bm/bm mouse (D) which correlates with the changes seen in the mCT scan [Fig. 1(D)].
421Osteoarthritis and Cartilage Vol. 13, No. 5The complete set of serial alternate sections of each knee
joint was examined on a Leitz DMRB microscope (Leica).
Joints were individually assessed by the grading system of
Maier and Wilhelmi15, with scoring based on a scale of 0e4,
with 4 being the most severe. Statistical analysis was
performed using a ManneWhitney (Wilcoxon) test.
Results
mCT ANALYSIS OF BM/BM LIMBS
Volumetric 3D renderings, based upon the mCT data,
revealed striking morphological differences between wild-
type and bm/bm limbs. In general, the bones of the bm/bm
mice appeared more robust due to their reduced diaphyseal
lengths and relatively enlarged epiphyses. This is illustrated
in the humeri shown in Fig. 1(A). Along with this diaphyseal
shortening, metaphyseal ﬂaring was a distinctive charac-
teristic of bm/bm long bones. In the femur, for example, this
ﬂaring was associated with a pronounced change in the
shape of the distal epiphysis, associated with an extensive
alteration in the conﬁguration of the patello-femoral groove
that resulted in the distal femurs having a hammer head-like
shape [Fig. 1(D)]. This alteration was also clearly evident in
histological sections of the distal bm/bm femur, as seen in
Fig. 2(D). Additional changes in bm/bm limbs included
enlarged muscle and tendon insertion points, as seen in the
deltoid [Fig. 1(A)] and tibial [Fig. 1(D)] tuberosities. Bowing
of the tibia and ﬁbula [Fig. 1(BeD)] was also present, as
was evidence of abnormal radiodensities about the knee
(osteophytosis) and irregularities of menisci in bm/bmsamples. The abnormal morphology of the distal femur
was also evident histologically [Fig. 2(B, D)]. We compared
proximal tibial subchondral plate thicknesses between wild-
type and bm/bm tibiae to search for the possibility of an
abnormality in subchondral bone structure, but found no
signiﬁcant difference (bmZ 122 mm, wild-typeZ 119, t test,
two tailed, PZ 0.7).
HISTOLOGICAL ANALYSIS OF BM/BM KNEE JOINTS
While the synovial lining of control of 6e7-month
C57BL/6 mice was approximately 1e2 cells thick
[Fig. 3(A)], the lining of brachymorph knees appeared
thickened and hypercellular [Fig. 3(B)]. The same was
observed for our 12e14-month knees (data not shown).
The signiﬁcance of this synovial hypertrophy is unclear,
but suggests the presence of a chronic low-grade in-
ﬂammation. In control mice, the narrow yet well-organized
epiphyseal growth plates were consistent with slowed
growth of long bones. These plates showed a columnar
organization of cells and an organized progression from
proliferating to hypertrophic cells [Fig. 3(C)]. As previously
reported, the growth plates of bm/bm mice were abnormal,
lacking the regular columnar organization of proliferating
and hypertrophying chondrocytes of C57BL/6 mice
[Fig. 3(D)]. Indeed, in the bm/bm samples there was no
clear distinction between the different zones of the growth
plate, with these tending to collapse into disorganized,
often round, clumps of cells. The epiphyseal growth plates
of the 12-month-old bm/bm also appeared less cellular
than those of controls and showed evidence of impairedFig. 3. Synovial lining of control (A) and bm/bm (B) mice at 6e9 months of age. Note the thickened synovium in B as indicated by arrows
compared to the control (A). Representative growth plates of control (C) and bm/bm (D) mice at 6e9 months of age.
422 A. F. Ford-Hutchinson et al.: Joint disease in Papss2 deﬁcient miceendochondral ossiﬁcation, with accumulation of mineral-
ized cartilage matrix.
Knee joints of 6e9-month-old C57BL/6 mice exhibited
histologically normal articular cartilage with regularly dis-
tributed and densely packed chondrocytes on all joint
surfaces [Fig. 4(A)]. At 12e14 months, all knee joints
isolated from C57BL/6 mice showed some areas of
superﬁcial ﬁbrillation in the medial joint compartment, and
occasional fraying, typically on the tibiae but also on
femoral condyles [Fig. 4(B)]. This was consistent with the
age-related cartilage degeneration (grade 1) seen in this
inbred strain.
At 6e7 months of age, bm/bm knee joints showed normal
appearing articular cartilage in all joint compartments,
although all samples exhibited some degree of fraying or
shredding of the thin central portions of the menisci
[Fig. 4(C)]. Simple or complex tears of the medial meniscus
were seen in all brachymorph joints obtained from
12-month-old animals [Fig. 4(D)]. At 12 months of age,
degenerative changes were evident in the medial and/or
patello-femoral compartments of all mutant mouse samples
(Fig. 5). All bm/bm mice exhibited degradation of the
articular cartilage on medial tibial plateaus [Fig. 5(A, B)],
although the opposing femoral cartilage remained intact in
most cases. Fragmentation and loss of tissue down to the
level of the tidemark was seen in half the bm/bm animals
[Fig. 5(A, B)]; with the remainder showing either horizontal
ruptures along the tidemark, considered a precursor to
cartilage loss (data not shown), or deep ﬁbrillations (datanot shown). The patello-femoral compartment was irregular
in all brachymorph mice and half the joints had erosions on
the patella and/or femur [Fig. 5(C, D)]. Interestingly, despite
the advanced degenerative changes in the patello-femoral
and medial joint compartments, the lateral compartments
consistently presented a normal appearance (data not
shown). Applying the grading system of Maier and
Wilhelmi15, the 12-month-old C57BL/6 knees had a mean
score of 1.2, while the score for bm/bm mice was 2.5
(Table I). A ManneWhitney (Wilcoxon) test was performed
where UZ 3.45, P! 0.001. It was thus concluded that the
bm/bm mutation on a C57BL/6 background was associated
with premature degenerative joint disease.
Discussion
Although the cartilage of brachymorph mice is reported to
be undersulfated, normal amounts of GAGs and matrix
collagens are apparently present7,16. Vanky et al.9, have
shown that this undersulfation leads to changes in the
epiphyseal growth plate cartilage, leading to impaired
longitudinal growth. Interestingly, changes in the sulfation
of proteoglycans has also been observed within osteoar-
thritic joints, although this phenomenon is primarily due to
enzymatic degradation and depletion of matrix GAGs,
rather than hyposulfation17,18. In addition to an alteration
in the physical properties of hyposulfated ECM molecules
that may result in instability, a decreased ability ofFig. 4. Sagittal section of representative C57BL/6 control (A, B) and bm/bm mice (C, D). Six month (A) and 12-month-old (B) control mice.
Minor ﬁbrillation of condylar cartilage is seen in (B) (see arrows). Meniscal fraying can be seen in the 6-month-old knee (C) and, more
pronounced, in a representative 12-month-old (D) knee (see arrows).
423Osteoarthritis and Cartilage Vol. 13, No. 5Fig. 5. Sagittal sections of representative 12-month-old bm knees. Medial compartment shows grade 2 and 3 changes in the articular cartilage
(A, B). The grade 3 changes in (A) reveals a loss of a large area of articular cartilage right down to the tidemark, grade 2 changes are depicted
in (B). Patello-femoral compartments showing surface damage of the articular cartilage (C) and deep ﬁssuring of the cartilage (D) on the
femoral side of this joint as illustrated by arrow.proteoglycans (such as syndecans which are involved in
ligand binding19, decorin, and biglycan20) to present growth
factors alters the growth, maintenance, and repair of
articular cartilage.
The abnormalities of the ECM in all likelihood contribute to
the degenerative changes seen in the articular cartilage of
12-month-old bmmice. ECM is supported through a network
of collagen ﬁbrils that are highly organized and stabilized via
both inter- and intra-molecular cross links21. These resist the
swelling pressure due to the negatively charged aggregates
of aggrecan22. These negative charges, mainly due to
chondroitin, are important in maintaining the structure of
proteoglycans aggregates23. Loss of these charges, as seen
in Papss2 deﬁciency, may cause structural instability in
addition to insufﬁcient water attraction and movement within
the ECM, both leading to weakness and or instability of load-
bearing joints. This would be predicted to render the articular
cartilage more susceptible to damage and thence to
premature degenerative joint disease.
Taken together, such factors as abnormal growth factor
ligand binding and proteoglycan structure could readily
account for the cartilage degeneration observed in bm/bm
mouse knees. Other mouse models of degenerative joint
disease attributed to instabilities in the ECM, include mice
expressing truncated collagen type II transgene24 and the
collagen type IX knockout25 where an alteration in the
structural integrity of cartilage results from loss of a major
cross-linking collagen.Spontaneous degenerative knee joint disease has been
observed in the C57BL/6 strain. Thus, with age (after 15.5
months) enlargement of menisci as well as narrowing of the
joint space has been observed26,27. Histological evidence
of cartilage destruction as early as 6e8 months of age has
been reported, albeit with slow progression, whereby 80%
of mice examined showed signs at 16e18 months, and
almost all mice showed signs at 2 years28. However, the
reported changes were conﬁned primarily to the lateral side
of the tibio-femoral compartment29. The bm mice, on the
other hand, consistently exhibited high-grade cartilage
damage at an earlier age (12 months) in both the patello-
femoral and medial compartments of the knee. In addition,
bm animals developed cartilage damage much earlier and
of much greater severity than the C57BL/6 mice (Table I).
The C57BL/6 mice in our control group most likely exhibited
the types of changes that tend to occur spontaneously
in the C57BL/6 mouse strain. Therefore, we conclude that
the characteristic changes seen in all the 12-month-old bm/
bm mice we examined were due to the loss of Papss2 and
were not a feature of the C57BL/6 genetic background.
Abnormal biomechanical function of the knee joint, as
a consequence of altered morphology of the skeletal
elements, may have also played a role in degeneration of
the articular cartilage in bm/bm knees. Metaphyseal ﬂaring
and abnormal epiphyseal morphology observed in brachy-
morph mouse, are also characteristic of many dysplasias
resulting in dwarﬁsm in humans30,31. The ﬂaring in the
424 A. F. Ford-Hutchinson et al.: Joint disease in Papss2 deﬁcient micemetaphyseal region can be attributed to the capacity for
normal appositional growth in the diaphysis to occur while
endochondral ossiﬁcation in the physis is inhibited. The
epiphyseal growth plate of the bm/bm mice lacks the
organization seen in the control mice at all ages. This
ﬁnding is in agreement with other reports9,32. Vanky et al.9
found that the chondrocytes in the proliferating zone are in
the G0 phase of the cell cycle which would result in
a decrease in the number of hypertrophic cells. This paucity
of hypertrophic cells was conﬁrmed by our observations in
the epiphyseal growth plate of bm/bm mice9. Although we
made no attempt to identify abnormal joint kinematics or gait
disturbance in the mutant mice, the skeletal abnormalities
that we observed very likely resulted in abnormal contact
forces in the patello-femoral and medial compartments.
Precocious development of degenerative joint disease
has been associated with human chondrodystrophies33.
With respect to the bm/bm mice, the various morphological
alterations observed, including the bowing of the tibia and
ﬁbula, and the enlargement of muscle attachments such as
the tibial and deltoid tuberosities, plausibly reﬂect adaptive
attempts to compensate for the abnormal and dispropor-
tionate bone growth. These features might to some extent
also reﬂect a ‘‘muscle packing’’ problem in that the bm/bm
mice must accommodate muscles with similar cross-
sectional areas to support the nearly normal sized trunk
within a context of dramatically shortened limbs. The
increased bowing of long bones, altered sites of muscle
attachment relative to lever components, and the altered
ratio of joint surface area to long bone length could conspire
to produce dramatically altered joint mechanics. Such
changes, in turn, might contribute to cartilage degeneration
due to abnormal strain patterns.
Might polymorphisms of the human PAPSS2 gene have
a role in predisposition to human osteoarthritis? Xu et al.34,
examined a sample population and found different poly-
morphisms both within and outside of conserved regions of
the PAPSS2 gene, some of which could alter enzymatic
activity. Thus, a mutation causing hyposulfation of proteo-
glycans could potentially be used as an indicator of disease
predisposition. However, a study of PAPSS2 genes in
a Japanese population revealed no correlation between
those affected with knee osteoarthritis35. It remains possible
that a PAPPS2 polymorphism(s) in a different ethnic
population will be associated with susceptibility to osteoar-
thritis. In keeping with this, a form of human SEMD has been
Table I
Comparison of control and bm/bm OA grades
Control bm/bm
Mouse Score Mouse Score
1 1 7 2
2 1 8 2
3 1 9 2
4 1 10 3
5 1 11 3
6 2 12 3
Mean 1.2 2.5
Control mice include three males and three females 12e14
month C57BL/6 mice. bm/bm mice consisted of three males and
three females 12-month-old mice. 6e9-month C57Bl/6 and bm
were also examined (data not shown) and found to have a score
of 0. A ManneWhitney (Wilcoxon) test was performed where
UZ 3.45, P! 0.001.attributed to a mutation the PAPSS2 gene that results in
a truncated protein due to premature nonsense codon. This
results in a protein that is predicted to be reduced from 614
to 437 amino acids in length12. It is still unknown as to
whether this causes the transcript to be destabilized or
whether the truncated protein retains partial activity12.
Similarities between the human disease and the bm/bm
model have been noted by ul Haque et al.12. Of most interest
to our study is that humans lacking normal PAPSS2 activity
exhibit long bone shortening and bowing, and also show
degenerative joint disease, including evidence of knee joint
arthrosis. In the human SEMD families, radiographic
abnormalities of the hands and spine were also observed11.
It would be of interest to examine the spines of older bm/bm
mice to search for evidence of degeneration. Given the
premature development of degenerative knee joint disease
in the mutant mice and other similarities with the human
SEMD kindred, we propose that this mutant represents
a model of human PAPSS2 deﬁciency-associated arthrosis.
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